|
Market Closed -
Nasdaq
16:00:00 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 40.10 USD | +0.12% |
|
-0.12% | +11.36% |
| 09-15 | Vericel Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 02:35 PM | |
| 07-31 | Truist Raises Price Target on Vericel to $58 From $54, Keeps Buy Rating | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VCEL | Delayed | |
CBOE
| VCEL | Real-time | |
Boerse Muenchen
| ATQP | Real-time | |
Tradegate
| ATQP | Real-time | |
Deutsche Boerse AG
| ATQP | Delayed | |
Börse Stuttgart
| ATQP | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 41.07 | 48.31 | 47 |
| Spread/Res. | -2.36% | -16.99% | -14.68% |
| Spread/Supp. | +1.67% | +22.18% | +7.22% |
| Support | 39.44 | 32.82 | 37.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VCEL Stock
- Charts Vericel Corporation
Select your edition
All financial news and data tailored to specific country editions

















